The U.S. Department of Health and Human Services announced that the U.S. Food and Drug Administration is initiating the removal of broad “black ...

The U.S. FDA moves to remove black box warnings from hormone replacement therapy products used for menopause. Read more here.

The fate of the enhanced Affordable Care Act premium tax credits — initially bolstered during the pandemic — is still unclear ...

After a leading study caused the FDA to slap its most stringent warning on hormone replacement therapies for menopause more ...

Commissioner Marty Makary said the agency is asking drugmakers to remove the strict black box warnings, with the goal of encouraging more women to take them. Labels on the medicines currently list ...

Q2 2026 Earnings Call Transcript November 10, 2025 Beyond Air, Inc. misses on earnings expectations. Reported EPS is $-1.25 ...

Healthcare may not lead the next market rally, but current levels offer compelling risk/reward for contrarian investors ...

Increased revenue by 128% year over year (YoY) to $1.8 million Appointed Beyond Air Board member Bob Goodman as Interim Chief Commercial Officer Raised $12.0 million in debt financing; proforma cash, ...

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...

The HHS has announced changes to estrogen hormone therapy black box labeling for menopause treatment in a move that they said corrects misleading warnings.HHS Secretary Robert F. Kennedy Jr. said in a ...

Markets have turned upbeat amid optimism that the 39-day US shutdown could soon come to an end, after a weekend of dealmaking in Washington. A new bill quickly advanced in a key S ...